NCI periodically provides updates on new websites and other online content of interest to the cancer community. See selected content that has been added as of December 2023.
In a clinical trial, a simple letter and phone call helped increase the number of people who had an abnormal cancer screening result to complete the recommended follow-up testing.
The activity of 34 genes can accurately predict the aggressiveness of meningiomas, a new study shows. This gene expression signature may help oncologists select the best treatments for people with this common type of brain cancer than they can with current methods.
In a clinical trial, people being treated for cancer who participated in virtual mind–body fitness classes were less likely to be hospitalized, and had shorter stays when they were hospitalized, than people who did not take the classes.
Antibodies currently used in many cancer treatments have only been able to reach proteins outside of cancer cells. In a new study in mice, scientists found a way to target cancer-fueling KRAS and IDH1 proteins buried inside cancer cells.
NCI’s James H. Doroshow, M.D., reflects on the accomplishments of NCI-MATCH, a first-of-its-kind precision medicine cancer trial, and gives an overview of three new successor trials: ComboMATCH, MyeloMATCH, and iMATCH.